Clinical Trials Directory

Trials / Unknown

UnknownNCT01572285

Transforaminal Epidural Steroid Injection to Treat Hemiplegic Shoulder Pain

Transforaminal Epidural Steroid Injection to Treat Hemiplegic Shoulder Pain : A Randomized, Sham-Controlled, Proof of Principle Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University of Sao Paulo General Hospital · Academic / Other
Sex
All
Age
50 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether transforaminal dexamethasone injections are effective in the treatment of chronic Hemiplegic Shoulder Pain.

Detailed description

Shoulder pain is the most common complication in hemiplegia after Stroke (CVA). Almost three quarters of all patients with hemiplegia will suffer from shoulder pain in the first twelve months after stroke. Because of the lack of effective treatment today, the optimal management of hemiplegic shoulder pain is prevention. Although widely studied, all clinical trials for shoulder pain in stroke fail to show efficacy. TF was never investigated to treat Hemiplegic Shoulder Pain (HSP). The investigators hypothesize that injecting the epidural space at the C6 level via transforaminal would desensitize both central medullary components of pain as peripheral sensitized structures such as the suprascapular nerve of the affected shoulder. To test this hypothesis, the investigators developed a treatment protocol consisting of two C6 transforaminal epidural steroid injection with dexamethasone (TF with 0.5mL of lidocaine 1% and 1.5mL of Dexamethasone 10mg/ml). This procedure was compared to a sham intervention.

Conditions

Interventions

TypeNameDescription
PROCEDUREtransforaminal dexamethasone injectionSubjects received transforaminal infiltration of lidocaine 1% 0.5mL and 1.5mL of Dexamethasone 10mg/ml
PROCEDUREShamSham procedure using a non-penetrating needle

Timeline

Start date
2011-10-01
Primary completion
2012-05-01
Completion
2012-11-01
First posted
2012-04-06
Last updated
2012-04-06

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01572285. Inclusion in this directory is not an endorsement.